Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthma
Open Access
- 26 June 2014
- journal article
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 24 (1) , 14019
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized TrialThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised studyBMC Pulmonary Medicine, 2014
- Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPDBMC Pulmonary Medicine, 2013
- Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthmaEuropean Respiratory Journal, 2013
- Inhaler competence in asthma: Common errors, barriers to use and recommended solutionsRespiratory Medicine, 2013
- Inhaler device, administration technique, and adherence to inhaled corticosteroids in patients with asthmaPrimary Care Respiratory Journal, 2011
- A Study on the Clinical Equivalence and Patient Preference of Fluticasone Propionate 250 μg Twice Daily via the DiskusTM/AccuhalerTMInhaler or the DiskhalerTM* Inhaler in Adult Asthmatic PatientsJournal of Asthma, 1998
- Effects of instruction by practice assistants on inhaler technique and respiratory symptoms of patients. A controlled randomized videotaped intervention studyFamily Practice, 1996
- Comparison of DiskusTMInhaler, a New Multidose Powder Inhaler, with DiskhalerTMInhaler for the Delivery of Salmeterol to Asthmatic PatientsJournal of Asthma, 1995